CMPUY: AI 评分 48/100 — AI 分析 (4月 2026)

概要：

CMPUY是做什么的？

CMPUY的投资论点是什么？

CMPUY在哪个行业运营？

CMPUY有哪些增长机遇？

• Expansion of Digital Health Solutions: CompuGroup Medical has the opportunity to expand its digital health solutions, including consumer portals and mobile apps. The digital health market is experiencing rapid growth, driven by increasing consumer demand for convenient and accessible healthcare services. By enhancing its digital offerings, CompuGroup Medical can attract new customers and increase revenue. The global digital health market is projected to reach $660 billion by 2025, presenting a substantial growth opportunity for the company.
• Integration of Healthcare Systems: The increasing demand for integrated healthcare systems presents a significant growth opportunity for CompuGroup Medical. Healthcare providers are seeking solutions that can seamlessly integrate data across different systems, improving efficiency and patient care. CompuGroup Medical can capitalize on this trend by developing and offering integrated solutions that connect ambulatory, pharmacy, hospital, and consumer health systems. This integration can lead to increased customer loyalty and higher revenue.
• Geographic Expansion: CompuGroup Medical can pursue geographic expansion to tap into new markets and increase its global presence. Emerging markets, in particular, offer significant growth potential due to increasing healthcare spending and the adoption of digital health technologies. By expanding into these markets, CompuGroup Medical can diversify its revenue streams and reduce its reliance on mature markets. This expansion requires careful market analysis and strategic partnerships to navigate local regulations and cultural differences.
• Strategic Acquisitions: CompuGroup Medical can pursue strategic acquisitions to expand its product portfolio and market share. Acquiring companies with complementary technologies or customer bases can accelerate growth and enhance the company's competitive position. Potential acquisition targets include companies specializing in telehealth, data analytics, or cybersecurity for healthcare providers. These acquisitions should be carefully evaluated to ensure they align with CompuGroup Medical's overall strategy and create synergies.
• Data Analytics and AI: CompuGroup Medical can leverage data analytics and artificial intelligence (AI) to improve its products and services. By analyzing healthcare data, the company can identify trends, predict patient outcomes, and personalize treatment plans. AI can also be used to automate tasks, improve efficiency, and reduce costs. Investing in data analytics and AI capabilities can enhance CompuGroup Medical's competitive advantage and drive innovation in the healthcare IT sector. The market for AI in healthcare is expected to reach $34 billion by 2025.

• CompuGroup Medical operates in four segments: Ambulatory Information Systems (AIS), Pharmacy Information Systems (PCS), Hospital Information Systems (HIS), and Consumer & Health Management Information Systems (CHS).
• The company serves a global market, providing healthcare IT solutions to various healthcare providers and consumers.
• CompuGroup Medical's gross margin stands at 83.6%, indicating strong pricing power and efficient cost management in its software and IT solutions.
• The company's market capitalization is $1.19 billion, reflecting its significant presence in the healthcare IT sector.
• CompuGroup Medical has a dividend yield of 0.22%, offering a modest income stream for investors.

CMPUY提供哪些产品和服务？

• Develops and sells software for ambulatory information systems (AIS).
• Provides software solutions for pharmacy information systems (PCS).
• Offers clinical and administrative solutions for hospital information systems (HIS).
• Creates consumer and health management information systems (CHS).
• Delivers IT security services for healthcare providers.
• Provides data-based product offers and software interfaces for information sharing.
• Offers clinical decision-making support and medication databases.
• Develops digital healthcare stock, consumer portals, and mobile apps.

CMPUY如何赚钱？

• Software Licensing: Generates revenue through licensing its software solutions to healthcare providers and pharmacies.
• Subscription Services: Offers subscription-based services for ongoing access to its software and related support.
• IT Services: Provides IT security services and data-based product offers to healthcare organizations.
• Data Analytics: Leverages healthcare data to provide insights and analytics to improve patient outcomes and efficiency.

• Registered physicians and medical care centers.
• Pharmacies and pharmaceutical companies.
• Acute care hospitals and rehabilitation centers.
• Health insurance companies.
• Consumers seeking digital health solutions.

• Established Customer Base: Long-standing relationships with a diverse customer base in the healthcare sector.
• Integrated Solutions: Comprehensive suite of integrated software solutions across ambulatory, pharmacy, hospital, and consumer health segments.
• Regulatory Expertise: Deep understanding of healthcare regulations and compliance requirements.
• Data Assets: Proprietary data assets and analytics capabilities that provide valuable insights to customers.

什么因素可能推动CMPUY股价上涨？

• Ongoing: Increasing adoption of digital health solutions by healthcare providers and consumers.
• Ongoing: Expansion of integrated healthcare systems and data analytics capabilities.
• Upcoming: Potential strategic acquisitions to expand product offerings and market share.
• Ongoing: Government initiatives promoting electronic health records and telehealth services.
• Ongoing: Growing demand for IT security services in the healthcare sector.

CMPUY的主要风险是什么？

• Potential: Intense competition from other healthcare IT providers.
• Potential: Evolving regulatory landscape and compliance requirements.
• Potential: Cybersecurity threats and data breaches.
• Potential: Economic downturns affecting healthcare spending.
• Ongoing: Currency risk associated with the ADR structure.

CMPUY的核心优势是什么？

• Comprehensive product portfolio across multiple healthcare segments.
• Established presence in the European healthcare IT market.
• Strong gross margin of 83.6%.
• Focus on integrated healthcare solutions.

CMPUY的劣势是什么？

• Relatively low profit margin of 1.5%.
• Dependence on regulatory compliance and healthcare policies.
• Limited presence in some emerging markets.
• High P/E ratio of 89.71.

CMPUY有哪些机遇？

• Expansion into new geographic markets.
• Growth in the digital health solutions market.
• Strategic acquisitions to expand product offerings.
• Increased demand for integrated healthcare systems.

CMPUY面临哪些威胁？

• Intense competition from other healthcare IT providers.
• Evolving regulatory landscape and compliance requirements.
• Cybersecurity threats and data breaches.
• Economic downturns affecting healthcare spending.

CMPUY的竞争对手是谁？

• Allscripts Healthcare Solutions — Offers a range of healthcare IT solutions, including electronic health records and practice management systems. — (BITGF)
• Cerner — Provides healthcare information technology solutions and services, including electronic health records and revenue cycle management. — (BTTAY)
• Change Healthcare — Focuses on providing healthcare technology solutions for revenue cycle management and clinical decision support. — (CSWYF)
• Teladoc Health — Offers telehealth services and virtual care solutions. — (DGWPF)
• athenahealth — Provides cloud-based electronic health records and practice management solutions. — (DWRKF)

Key Metrics

• MoonshotScore: 48/100

Company Profile

• CEO: Daniel Gotthardt
• Headquarters: Koblenz, DE
• Employees: 8,299
• Founded: 2012

AI Insight

• ADR Level: 1
• ADR Ratio: 1:1
• Home Market Ticker: CMPU

• OTC Tier: OTC Other
• Disclosure Status: Unknown